Zurich University
of Applied Sciences

Adcancing drug development: 3D CoSeedis Immuno-Micro-Tumor System

Description

This collaboration between abc biopply, ZHAW Zurich University of Applied Sciences, and University of Zurich aims to advance drug development by introducing a novel 3D CoSeedis Immuno-Micro-Tumor System.

The new system will encompass heterotypic cancer organoids, consisting of cancer, stromal and immune cells, embedded in an extracellular matrix, which offer a physiologically relevant microenvironment for testing new immunotherapies.

Key data

Projectlead

Prof. Dr. Steffi Lehmann

Project team

Lynn Gasser

Project partners

Universität Zürich UZH; abc biopply ag

Project status

ongoing, started 09/2025

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Innosuisse Innovationsprojekt

Portrait photo of Prof. Dr. Steffi Lehmann

Prof. Dr. Steffi Lehmann

School of Life Sciences and Facility Management
Einsiedlerstrasse 31
8820 Wädenswil

+41 (0) 58 934 50 64
steffi.lehmann@zhaw.ch

go back

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.